We are live on ! Find out more
MTACU

MedTech Acquisition Corporation Unit
MTACU

Delisted

MTACU was delisted on the 10th of August, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in MedTech Acquisition Corporation Unit in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $1.35K → $0 (-$1.35K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$1.32K
2
DM
Deerfield Management
New York
-$10
3
Wells Fargo
Wells Fargo
California
-$10
4
CS
Clear Street
New York
-$9
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
1
Tower Research Capital (TRC)
New York
– -$1.32K -128 Closed
CS
2
Clear Street
New York
– -$9 -1 Closed
DM
3
Deerfield Management
New York
– -$10 -1 Closed
Wells Fargo
4
Wells Fargo
California
– -$10 -1 Closed

MTACU Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q3 2023, worth a combined $0 — down 100% from $1.35K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of MTACU and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $1.32K sold.

  • 0 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q3 2023, down from 4 in Q2 2023.
  • Funds reported $0 of MedTech Acquisition Corporation Unit stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new MedTech Acquisition Corporation Unit positions in Q3 2023 and 4 closed out, a net change of -4 holders.
  • The largest MedTech Acquisition Corporation Unit seller in Q3 2023 was Tower Research Capital (TRC), an estimated $1.32K sold.

Based on aggregated 13F filings for Q3 2023.